1. Home
  2. EVTC vs TYRA Comparison

EVTC vs TYRA Comparison

Compare EVTC & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evertec Inc.

EVTC

Evertec Inc.

HOLD

Current Price

$29.36

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$36.66

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTC
TYRA
Founded
1988
2018
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
EVTC
TYRA
Price
$29.36
$36.66
Analyst Decision
Hold
Strong Buy
Analyst Count
5
11
Target Price
$35.80
$47.50
AVG Volume (30 Days)
270.3K
1.0M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
0.66%
N/A
EPS Growth
27.17
N/A
EPS
2.20
N/A
Revenue
$453,869,000.00
N/A
Revenue This Year
$12.68
N/A
Revenue Next Year
$6.86
N/A
P/E Ratio
$13.83
N/A
Revenue Growth
11.48
N/A
52 Week Low
$24.95
$8.75
52 Week High
$38.56
$40.65

Technical Indicators

Market Signals
Indicator
EVTC
TYRA
Relative Strength Index (RSI) 50.90 52.57
Support Level $28.83 $34.01
Resistance Level $30.25 $39.90
Average True Range (ATR) 0.80 1.87
MACD 0.12 -0.11
Stochastic Oscillator 40.34 43.77

Price Performance

Historical Comparison
EVTC
TYRA

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. It derives maximum revenue from Latin America Payments and Solutions. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: